Literature DB >> 31338742

Myriad Faces of Chronic Granulomatous Disease: All in an Indian Family with Novel CYBB Defect.

Pandiarajan Vignesh1, Madhubala Sharma1, Rakesh Kumar Pilania1, Jitendra Kumar Shandilya1, Anit Kaur1, Shubham Goel1, Anupriya Kaur2, Deepti Suri1, Amit Rawat3, Ashwin Dalal4, Asodu Sandeep Sarma4, Surjit Singh1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31338742     DOI: 10.1007/s10875-019-00661-0

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


× No keyword cloud information.
  10 in total

Review 1.  Hematologically important mutations: X-linked chronic granulomatous disease (third update).

Authors:  Dirk Roos; Douglas B Kuhns; Anne Maddalena; Joachim Roesler; Juan Alvaro Lopez; Tadashi Ariga; Tadej Avcin; Martin de Boer; Jacinta Bustamante; Antonio Condino-Neto; Gigliola Di Matteo; Jianxin He; Harry R Hill; Steven M Holland; Caroline Kannengiesser; M Yavuz Köker; Irina Kondratenko; Karin van Leeuwen; Harry L Malech; László Marodi; Hiroyuki Nunoi; Marie-José Stasia; Anna Maria Ventura; Carl T Witwer; Baruch Wolach; John I Gallin
Journal:  Blood Cells Mol Dis       Date:  2010-08-21       Impact factor: 3.039

Review 2.  Chronic granulomatous disease.

Authors:  Dirk Roos
Journal:  Br Med Bull       Date:  2016-03-16       Impact factor: 4.291

3.  Infection Profile in Chronic Granulomatous Disease: a 23-Year Experience from a Tertiary Care Center in North India.

Authors:  Amit Rawat; Pandiarajan Vignesh; Avinash Sharma; Jitendra K Shandilya; Madhubala Sharma; Deepti Suri; Anju Gupta; Vikas Gautam; Pallab Ray; Shivaprakash M Rudramurthy; Arunaloke Chakrabarti; Kohsuke Imai; Shigeaki Nonoyama; Osamu Ohara; Yu L Lau; Surjit Singh
Journal:  J Clin Immunol       Date:  2017-03-22       Impact factor: 8.317

4.  X-linked carriers of chronic granulomatous disease: Illness, lyonization, and stability.

Authors:  Beatriz E Marciano; Christa S Zerbe; E Liana Falcone; Li Ding; Suk See DeRavin; Janine Daub; Samantha Kreuzburg; Lynne Yockey; Sally Hunsberger; Ladan Foruraghi; Lisa A Barnhart; Kabir Matharu; Victoria Anderson; Dirk N Darnell; Cathleen Frein; Danielle L Fink; Karen P Lau; Debra A Long Priel; John I Gallin; Harry L Malech; Gulbu Uzel; Alexandra F Freeman; Douglas B Kuhns; Sergio D Rosenzweig; Steven M Holland
Journal:  J Allergy Clin Immunol       Date:  2017-05-18       Impact factor: 10.793

5.  Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus.

Authors:  Michelle Petri; Ana-Maria Orbai; Graciela S Alarcón; Caroline Gordon; Joan T Merrill; Paul R Fortin; Ian N Bruce; David Isenberg; Daniel J Wallace; Ola Nived; Gunnar Sturfelt; Rosalind Ramsey-Goldman; Sang-Cheol Bae; John G Hanly; Jorge Sánchez-Guerrero; Ann Clarke; Cynthia Aranow; Susan Manzi; Murray Urowitz; Dafna Gladman; Kenneth Kalunian; Melissa Costner; Victoria P Werth; Asad Zoma; Sasha Bernatsky; Guillermo Ruiz-Irastorza; Munther A Khamashta; Soren Jacobsen; Jill P Buyon; Peter Maddison; Mary Anne Dooley; Ronald F van Vollenhoven; Ellen Ginzler; Thomas Stoll; Christine Peschken; Joseph L Jorizzo; Jeffrey P Callen; S Sam Lim; Barri J Fessler; Murat Inanc; Diane L Kamen; Anisur Rahman; Kristjan Steinsson; Andrew G Franks; Lisa Sigler; Suhail Hameed; Hong Fang; Ngoc Pham; Robin Brey; Michael H Weisman; Gerald McGwin; Laurence S Magder
Journal:  Arthritis Rheum       Date:  2012-08

Review 6.  Giuffrè-Tsukahara syndrome: Evidence for X-linked dominant inheritance and review.

Authors:  Ashwin B Dalal; Anujit Sarkar; T Padma Priya; Madhusudan R Nandineni
Journal:  Am J Med Genet A       Date:  2010-08       Impact factor: 2.802

7.  Pioglitazone restores phagocyte mitochondrial oxidants and bactericidal capacity in chronic granulomatous disease.

Authors:  Ruby F Fernandez-Boyanapalli; S Courtney Frasch; Stacey M Thomas; Kenneth C Malcolm; Michael Nicks; Ronald J Harbeck; Claudia V Jakubzick; Raphael Nemenoff; Peter M Henson; Steven M Holland; Donna L Bratton
Journal:  J Allergy Clin Immunol       Date:  2014-12-10       Impact factor: 10.793

Review 8.  A review of trisomy X (47,XXX).

Authors:  Nicole R Tartaglia; Susan Howell; Ashley Sutherland; Rebecca Wilson; Lennie Wilson
Journal:  Orphanet J Rare Dis       Date:  2010-05-11       Impact factor: 4.123

9.  The origin of 47,XXY and 47,XXX aneuploidy: heterogeneous mechanisms and role of aberrant recombination.

Authors:  M MacDonald; T Hassold; J Harvey; L H Wang; N E Morton; P Jacobs
Journal:  Hum Mol Genet       Date:  1994-08       Impact factor: 6.150

10.  Pioglitazone as a novel therapeutic approach in chronic granulomatous disease.

Authors:  Maddalena Migliavacca; Andrea Assanelli; Francesca Ferrua; Maria Pia Cicalese; Alessandra Biffi; Marta Frittoli; Paolo Silvani; Giovanna Chidini; Edoardo Calderini; Anna Mandelli; Anna Camporesi; Raffaella Milani; Giada Farinelli; Roberto Nicoletti; Fabio Ciceri; Alessandro Aiuti; Maria Ester Bernardo
Journal:  J Allergy Clin Immunol       Date:  2016-04-04       Impact factor: 10.793

  10 in total
  1 in total

1.  Clinical, Immunological, and Molecular Profile of Chronic Granulomatous Disease: A Multi-Centric Study of 236 Patients From India.

Authors:  Amit Rawat; Pandiarajan Vignesh; Murugan Sudhakar; Madhubala Sharma; Deepti Suri; Ankur Jindal; Anju Gupta; Jitendra Kumar Shandilya; Sathish Kumar Loganathan; Gurjit Kaur; Sanchi Chawla; Pratap Kumar Patra; Alka Khadwal; Biman Saikia; Ranjana Walker Minz; Vaishali Aggarwal; Prasad Taur; Ambreen Pandrowala; Vijaya Gowri; Mukesh Desai; Manasi Kulkarni; Gauri Hule; Umair Bargir; Priyanka Kambli; Manisha Madkaikar; Sagar Bhattad; Chetan Ginigeri; Harish Kumar; Ananthvikas Jayaram; Deenadayalan Munirathnam; Meena Sivasankaran; Revathi Raj; Ramya Uppuluri; Fouzia Na; Biju George; Harsha Prasada Lashkari; Manas Kalra; Anupam Sachdeva; Shishir Seth; Tapas Sabui; Aman Gupta; Karin van Leeuwen; Martin de Boer; Koon Wing Chan; Kohsuke Imai; Osamu Ohara; Shigeaki Nonoyama; Yu Lung Lau; Surjit Singh
Journal:  Front Immunol       Date:  2021-02-25       Impact factor: 7.561

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.